CAPITOL COUNSEL LLC

Lobbying for ARDELYX, INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Health Issues

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Medicare/Medicaid

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.